Literature DB >> 12079835

Insulin stimulation of hepatic triacylglycerol secretion in the insulin-replete state: implications for the etiology of peripheral insulin resistance.

Victor A Zammit1.   

Abstract

Observations on humans, on rats in vivo, and on isolated perfused rat livers indicate that insulin stimulates hepatic very-low-density lipoprotein (VLDL)-TAG secretion when the liver is chronically exposed to the hormone. They suggest that frequent stimulation of insulin secretion throughout the diurnal cycle may result in a chronic stimulation of VLDL secretion and increased delivery of acyl moieties to the periphery, particularly to muscle, the most important site of insulin-sensitive glucose disposal. If acyl groups are provided in excess of the oxidative needs of the tissue, this may lead to induction of insulin resistance, irrespective of whether obesity is established concomitantly. Dietary factors that stimulate hepatic VLDL secretion may have the same effect and contribute to the induction of a vicious spiral leading to the development of the full-blown Metabolic Syndrome and its pathological consequences, including type-2 diabetes, stroke, and cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12079835     DOI: 10.1111/j.1749-6632.2002.tb04263.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  11 in total

Review 1.  Heart and liver fatty acid binding proteins and the metabolic syndrome.

Authors:  Bert Binas
Journal:  Curr Hypertens Rep       Date:  2005-12       Impact factor: 5.369

2.  Inhibition of insulin and T3-induced fatty acid synthase by hexanoate.

Authors:  Murielle M Akpa; Floriane Point; Sabine Sawadogo; Anne Radenne; Catherine Mounier
Journal:  Lipids       Date:  2010-09-01       Impact factor: 1.880

3.  Apolipoprotein AII is a regulator of very low density lipoprotein metabolism and insulin resistance.

Authors:  Lawrence W Castellani; Cara N Nguyen; Sarada Charugundla; Michael M Weinstein; Chau X Doan; William S Blaner; Nuttaporn Wongsiriroj; Aldons J Lusis
Journal:  J Biol Chem       Date:  2007-12-26       Impact factor: 5.157

4.  Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis.

Authors:  Sudha B Biddinger; Antonio Hernandez-Ono; Christian Rask-Madsen; Joel T Haas; José O Alemán; Ryo Suzuki; Erez F Scapa; Chhavi Agarwal; Martin C Carey; Gregory Stephanopoulos; David E Cohen; George L King; Henry N Ginsberg; C Ronald Kahn
Journal:  Cell Metab       Date:  2008-02       Impact factor: 27.287

5.  Sexual dimorphism in the lasting effects of moderate caloric restriction during gestation on energy homeostasis in rats is related with fetal programming of insulin and leptin resistance.

Authors:  Mariona Palou; Teresa Priego; Juana Sánchez; Andreu Palou; Catalina Picó
Journal:  Nutr Metab (Lond)       Date:  2010-08-26       Impact factor: 4.169

6.  Effects of citral, a naturally occurring antiadipogenic molecule, on an energy-intense diet model of obesity.

Authors:  Tamonud Modak; Abhilash Mukhopadhaya
Journal:  Indian J Pharmacol       Date:  2011-05       Impact factor: 1.200

7.  Prevalence, predisposition and prevention of type II diabetes.

Authors:  Dong Cheng
Journal:  Nutr Metab (Lond)       Date:  2005-10-18       Impact factor: 4.169

8.  Carbohydrate restriction improves the features of Metabolic Syndrome. Metabolic Syndrome may be defined by the response to carbohydrate restriction.

Authors:  Jeff S Volek; Richard D Feinman
Journal:  Nutr Metab (Lond)       Date:  2005-11-16       Impact factor: 4.169

Review 9.  Insulin resistance in cardiovascular disease, uremia, and peritoneal dialysis.

Authors:  Mark Lambie; Mario Bonomini; Simon J Davies; Domenico Accili; Arduino Arduini; Victor Zammit
Journal:  Trends Endocrinol Metab       Date:  2021-07-12       Impact factor: 10.586

10.  Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal.

Authors:  Anthony Accurso; Richard K Bernstein; Annika Dahlqvist; Boris Draznin; Richard D Feinman; Eugene J Fine; Amy Gleed; David B Jacobs; Gabriel Larson; Robert H Lustig; Anssi H Manninen; Samy I McFarlane; Katharine Morrison; Jørgen Vesti Nielsen; Uffe Ravnskov; Karl S Roth; Ricardo Silvestre; James R Sowers; Ralf Sundberg; Jeff S Volek; Eric C Westman; Richard J Wood; Jay Wortman; Mary C Vernon
Journal:  Nutr Metab (Lond)       Date:  2008-04-08       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.